TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer.
Current treatment options for cancer, which include surgery, radiation and/or chemotherapy, are not adequately meeting patient treatment needs. Radiation and chemotherapy in particular are highly toxic and rarely “cure” the patient by permanently eliminating the cancer.